D. Samson Industries signs MoU with Faculty of Medicine, University of Colombo

Exchanging of the MoU between the University of Colombo and D. Samson Industries by University of Colombo Vice Chancellor Professor Chandrika Wijeyaratne and D. Samson Industries Ltd. Managing Director Kasun Rajapaksa 

D. Samson Industries recently signed a Memorandum of Understanding (MoU) with the Faculty of Medicine University of Colombo (FOMUOC). The objective of this partnership was to collaborate for the production of a Beta brand diabetic shoe range. 

University of Colombo Vice Chancellor Professor Chandrika Wijeyaratne, D. Samson Industries Ltd. Managing Director Kasun Rajapaksa, University of Colombo Faculty of Medicine Dean Professor Vajira Dissanayake, Department of Surgery Head Professor Mandika Wijeyaratne, Sports and Exercise Medicine Unit Coordinator Dr. Chathuranga Ranasinghe, Dr. Romain Perera, Dr. Thusitha Kahaduwa, DSI Director Dilshan Rajapaksa, DSI Business Development Manager Oshini Jayasooriya and DSI Assistant Business Development Manager Janaka Bandara were among those present at the signing of the MoU. 

The number of diabetic patients in Sri Lanka is currently growing at an alarming level which calls for urgent medical attention and focus from medical authorities such as FOMUOC and SLMA. Beta diabetic shoes, produced by D. Samson Industries, are specially designed shoes intended to offer protection for diabetic feet and reduce the risk of skin breakdown, primarily in case of poor circulation, neuropathy and foot abnormalities. It is necessary to make diabetic patients aware of the benefits of this diabetic footwear, which can protect their feet in every level.  Beta diabetic shoes are designed with a protective interior made with soft material and with no stitching, as sometimes even the smallest prominence can irritate and cause skin breakdown in diabetic foot. The top of the shoe is soft and stretchable to suit tender and deformed feet. In addition, beta diabetic shoes contain special insoles that provide support, conform to the contours of the foot and reduce pressure on the bottom of the foot. The specially designed lightweight soles of the shoes are designed to facilitate ease of mobility. 

The continuous improvement and development of the beta brand diabetic footwear will be undertaken with technical advice, research and support from the Faculty of Medicine University of Colombo. With the added advice and consultation of the NIROGI Lanka project of the Sri Lanka Medical Association, this footwear will be of optimal use to diabetic patients.